Oragenics appoints Natasha Giordano to board of directors effective Sept 1, 2025

ORAGENICS INC

Natasha Giordano appointed to Oragenics Board effective September 1, 2025.
Ms. Giordano brings experience from PLx Pharma (CEO), Matinas BioPharma board, and HCA.
She will receive annual base director fee of $45,000, pro-rated, and $3,750/month for Sept-Dec 2025.
She has agreed to stand for re-election at next annual meeting of shareholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.